Reslizumab is a medication that belongs to a class of drugs known as monoclonal antibodies. It is used to treat severe asthma in adults and adolescents who have not responded well to other asthma medications. Reslizumab works by targeting and blocking a specific protein in the body that is involved in the inflammation of the airways, which is a common feature of asthma.

This medication is typically administered through an intravenous infusion in a healthcare setting, usually once every four weeks. It is important to follow the dosing schedule recommended by your healthcare provider to ensure the best results from treatment.

As with any medication, there are potential side effects associated with reslizumab. These can include headache, fatigue, muscle pain, and injection site reactions. It is important to discuss any concerns or side effects with your healthcare provider.

It is also important to note that reslizumab is not a rescue medication for asthma attacks. It is intended to be used as a maintenance treatment to help control asthma symptoms and reduce the frequency of asthma attacks.

If you have been prescribed reslizumab for your asthma, it is important to continue taking your other asthma medications as prescribed by your healthcare provider. Do not stop or adjust your asthma medications without consulting your healthcare provider first.

Overall, reslizumab can be an effective treatment option for individuals with severe asthma who have not responded well to other medications. If you have any questions or concerns about reslizumab or your asthma treatment plan, be sure to discuss them with your healthcare provider.